Natural protection against HIV-1 infection provided by HIV-2.

Travers, K; Mboup, S; Marlink, R; Guèye-Nidaye, A; Siby, T; Thior, I; Traore, I; Dieng-Sarr, A; Sankalé, J L; Mullins, C

Travers, K; Mboup, S; Marlink, R; Guèye-Nidaye, A; Siby, T; Thior, I; Traore, I; Dieng-Sarr, A; Sankalé, J L; Mullins, C.

Affiliation

Travers K; Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA.

Science ; 268(5217): 1612-5, 1995 Jun 16.

Article in En | MEDLINE | ID: mdl-7539936

Subject(s)

HIV Infections/immunology; HIV-1/immunology; HIV-2/immunology; AIDS Vaccines; CD4 Lymphocyte Count; Cohort Studies; Confounding Factors, Epidemiologic; Cross Reactions; Epitopes/immunology; Female; HIV Antigens/immunology; HIV Infections/epidemiology; HIV Infections/prevention & control; HIV Infections/virology; HIV Seropositivity; HIV-1/pathogenicity; HIV-2/pathogenicity; Humans; Immunity, Innate; Multivariate Analysis; Prospective Studies; Regression Analysis; Senegal; Sex Work; Virulence

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: HIV Infections / HIV-1 / HIV-2 Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Africa Language: En Journal: Science Year: 1995 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links